AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: Monitoring Neonatal Abstinence Syndrome in buprenorphine-exposed IVF twins: a case study

Jan 5, 2017 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study
Laura Brandt, Patrick Swoboda, Gabriele Fischer, and Annemarie Unger
Substance Abuse Vol. 37 , Iss. 4,2016

This is the first case report on neonatal outcomes of IVF-conceived twins exposed to buprenorphine in utero including NAS course and treatment. In the present case (where no concomitant substance use occurred over month prior to delivery), the NAS treatment duration exceeds that reported for buprenorphine-exposed neonates in previous studies. Of note, the total neonatal morphine dose for both twins far exceeds the average reported by other publications. Considering that the staff in the present case was not blinded with regard to maternal medication and dose or the IVF-status, this may have led to concerns for using a more rapid tapering process. In light of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, a discussion of the presented case, and especially the treatment course in the neonates, with researchers and practitioners in the field but also with patient ombudsmen might have the potential to improve the human rights situation for such patients.

————————————————————————————————-
Our newly released issue is now online —> October-December 2016.
————————————————————————————————-

Filed Under: SAj Blog, The Authors' Own Words

Seth Godin on What We Deserve

Dec 20, 2016 by AMERSA

Seth Godin is a hero and mentor of Managing Editor Dan Harding.

Seth is an author, speaker, thought leader, and has been blogging daily insights for over 10 years.

A recent blog post nicely summarized why many of us do what we do with a fresh lens – a lens about what we deserve.

View the post here: http://sethgodin.typepad.com/seths_blog/2016/10/moral-hazard-is-no-excuse-for-our-inhumanity.html

————————————————————————————————-
Our newly released issue is now online —> October-December 2016.
————————————————————————————————-

Filed Under: SAj Blog, The Authors' Own Words, Uncategorized

Turning the Tide or Riptide? the Changing Opioid Epidemic

Nov 22, 2016 by AMERSA

wsub_a_1261070_f0002_b

Turning the Tide or Riptide? the Changing Opioid Epidemic
Stefan G. Kertesz
Substance Abuse
(The publisher has graciously made this article available to the public for download until January 31, 2017.)

Illustration by Lissa Mathis as published in Substance Abuse journal.

Filed Under: SAj Blog, The Authors' Own Words, Uncategorized

The Authors’ Own Words: Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings

Oct 20, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings
J. Deanna Wilson, Natalie Spicyn, Pamela Matson, Anika Alvanzo, and Leonard Feldman
Substance Abuse Vol. 37 , Iss. 3,2016

Our manuscript, “Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings” provides a novel and timely look at the knowledge, attitudes, and beliefs of Internal Medicine resident trainees regarding prescription of naloxone for overdose reversal in community settings, and towards addiction treatment more broadly. At a time when municipalities across the country are declaring states of emergency due to the opioid epidemic, it is more crucial than ever to examine how residents are trained on this potentially life-saving intervention, and to intervene with a targeted educational initiative during this influential period in their medical training, when the knowledge base and habits that inform their career are being shaped. The HOPE study is the first of its kind focusing specifically on physicians-in-training, and will help not only inform future educational initiatives, but will also serve as a proof-of-concept for the feasibility of implementing a successful overdose prevention program utilizing a harm-reduction paradigm from within the inpatient setting.

————————————————————————————————-
Our newly released issue is now online —> July-September 2016.
————————————————————————————————-

Filed Under: SAj Blog, The Authors' Own Words

The Authors’ Own Words: Molly users versus nonusers in a sample of college alcohol drinkers: Differences in substance-related harms and sensation seeking

Oct 19, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Molly users versus nonusers in a sample of college alcohol drinkers: Differences in substance-related harms and sensation seeking
Ashley N. Linden-Carmichael, Amy L. Stamates, Brynn E. Sheehan, and Cathy Lau-Barraco
Substance Abuse Vol. 37 , Iss. 3,2016

Molly is a form of MDMA that is perceived by some users to be more “pure” and possibly less harmful than other forms of MDMA.  To the best of our knowledge, our study was the first to examine prevalence, risks, and personality characteristics associated with Molly use in a college sample.  Our findings suggest that 12% of students sampled have used Molly.  In addition, Molly users report higher levels of sensation seeking, and Molly use is uniquely related to greater risk for substance-related harms.  These findings demonstrate a need for correcting possible misperceptions about Molly in addition to educating users on the potential for experiencing harm.

————————————————————————————————-
Our newly released issue is now online —> July-September 2016.
————————————————————————————————-

Filed Under: SAj Blog, The Authors' Own Words

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 38
  • Next Page »

Copyright © 2025
Site by: web360